DDrare: Database of Drug Development for Rare Diseases

Searched query = "Smith-Magenis syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Drug = CC; DTR Melatonin (NIH CC PDS); Device: Enviro-light artificial light box; Device: Phototherapy (Bright Light); Hourly dosing of the nychtemeral secretion of melatonin; Melatonin; Melatonin CR; RM-493; Setmelanotide; Tasimelteon

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03492970 (ClinicalTrials.gov)	March 7, 2018	1/3/2018	Melatonin in Adults With SMS	Characterization of Behavioral Disorders and 24 H-melatonin Level in Adults With Smith Magenis Syndrome	Smith Magenis Syndrome	Biological: Hourly dosing of the nychtemeral secretion of melatonin	Hôpital le Vinatier	Hospices Civils de Lyon	Completed	18 Years	65 Years	All	10	N/A	France

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT03492970
(ClinicalTrials.gov)

March 7, 2018

1/3/2018

Melatonin in Adults With SMS

Characterization of Behavioral Disorders and 24 H-melatonin Level in Adults With Smith Magenis Syndrome

Smith Magenis Syndrome

Biological: Hourly dosing of the nychtemeral secretion of melatonin

Hôpital le Vinatier

Hospices Civils de Lyon

Completed

18 Years

65 Years

All

N/A

France